W. R. Berkley’s elite specialty underwriting, 20.5% operating ROE, and disciplined capital returns support five-year upside despite moderating premium growth and premium valuation.
Overview
W. R. Berkley Corporation (WRB), founded in 1967, is a global commercial P&C specialty insurer organized through 60 independently managed businesses. Approximately 88% of net premiums written comes from Insurance and 12% from Reinsurance & Monoline Excess, with revenue generated from underwriting specialized commercial risks and investing premium float. **The core competitive advantage is decentralized underwriting expertise combined with large-company capital strength**, enabling rapid, customized risk selection for complex commercial clients. Q2 2026 demonstrated strong execution: diluted EPS was $1.15, up 15% year over year, operating EPS reached a record $1.27, gross premiums written rose 4.2% to $4.14 billion, and the 90.0% combined ratio improved 1.6 points despite 2.0 catastrophe-loss points. Operating ROE was 20.5%. The principal debate is valuation and growth normalization: WRB trades at approximately 15.2x forward P/E and 2.7x book value, while consensus is Hold and the mean target is $68.29 versus a $72.56 reference price. Near-term catalysts include reinvestment of the $30.69 billion portfolio, disciplined cycle management, and dividends and buybacks. The five-year probability-weighted target is $99.81.